comparemela.com

Latest Breaking News On - Fusion pharmaceuticals company profile - Page 2 : comparemela.com

Fusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 12-Month High at $21 32

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares traded. The stock had previously closed at $21.24. Analysts Set New Price Targets Several brokerages have issued reports on […]

Fusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 1-Year High at $21 32

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares trading hands. The stock had previously closed at $21.24. Analyst Ratings Changes Several analysts have commented on […]

Fusion Pharmaceuticals (NASDAQ:FUSN) Receives Hold Rating from Jonestrading

Jonestrading reaffirmed their hold rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. Several other research firms also recently weighed in on FUSN. Royal Bank of Canada reiterated a sector perform rating and issued a $21.00 target price (up previously from $16.00) […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.